| Product Code: ETC11626062 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The colorectal cancer drugs therapeutic import shipments to India showed impressive growth in 2024, with top exporting countries being Australia, USA, China, Ireland, and South Korea. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market, while the impressive Compound Annual Growth Rate (CAGR) of 19.64% from 2020 to 2024 showcases a thriving sector. Furthermore, the remarkable growth rate of 79.22% from 2023 to 2024 highlights the increasing demand for colorectal cancer drugs in the Indian market, suggesting promising opportunities for stakeholders in the industry.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Colorectal Cancer Drugs Therapeutic Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, 2021 & 2031F |
3.3 India Colorectal Cancer Drugs Therapeutic Market - Industry Life Cycle |
3.4 India Colorectal Cancer Drugs Therapeutic Market - Porter's Five Forces |
3.5 India Colorectal Cancer Drugs Therapeutic Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 India Colorectal Cancer Drugs Therapeutic Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 India Colorectal Cancer Drugs Therapeutic Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Colorectal Cancer Drugs Therapeutic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of colorectal cancer in India |
4.2.2 Growing awareness about early detection and treatment options |
4.2.3 Advancements in research and development of colorectal cancer drugs |
4.2.4 Rising healthcare expenditure and improving healthcare infrastructure in India |
4.3 Market Restraints |
4.3.1 High cost of colorectal cancer drugs |
4.3.2 Stringent regulatory requirements for drug approval |
4.3.3 Limited access to advanced treatment options in rural areas of India |
4.3.4 Presence of alternative treatment therapies |
5 India Colorectal Cancer Drugs Therapeutic Market Trends |
6 India Colorectal Cancer Drugs Therapeutic Market, By Types |
6.1 India Colorectal Cancer Drugs Therapeutic Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 India Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 India Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.1.4 India Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.1.5 India Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 India Colorectal Cancer Drugs Therapeutic Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 India Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 India Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.2.4 India Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Intramuscular, 2021 - 2031F |
6.2.5 India Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.2.6 India Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 India Colorectal Cancer Drugs Therapeutic Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 India Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.3.3 India Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.3.4 India Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
7 India Colorectal Cancer Drugs Therapeutic Market Import-Export Trade Statistics |
7.1 India Colorectal Cancer Drugs Therapeutic Market Export to Major Countries |
7.2 India Colorectal Cancer Drugs Therapeutic Market Imports from Major Countries |
8 India Colorectal Cancer Drugs Therapeutic Market Key Performance Indicators |
8.1 Patient survival rates post-treatment |
8.2 Adoption rate of new colorectal cancer drugs in the market |
8.3 Number of clinical trials for colorectal cancer drugs in India |
9 India Colorectal Cancer Drugs Therapeutic Market - Opportunity Assessment |
9.1 India Colorectal Cancer Drugs Therapeutic Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 India Colorectal Cancer Drugs Therapeutic Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 India Colorectal Cancer Drugs Therapeutic Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Colorectal Cancer Drugs Therapeutic Market - Competitive Landscape |
10.1 India Colorectal Cancer Drugs Therapeutic Market Revenue Share, By Companies, 2024 |
10.2 India Colorectal Cancer Drugs Therapeutic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |